Danaher splashes $2bn on dental implant firm Nobel
This article was originally published in Clinica
After several months of speculation, Danaher has agreed to buy number-two dental implant player Nobel Biocare for CHF17.10 ($18.27) per share. The all-cash deal is worth around $2.2bn, including assumed debt, and has been recommended by Nobel’s board of directors. The transaction is expected to close in late 2014 or early 2015.